Published in Hepatitis Weekly, November 16th, 2009
"Randomized, parallel-group trial conducted between September 2003 and February 2007. and researchers were not blinded to intervention assignment. Random assignment was centralized, computer-generated, and stratified by geographic region, hepatitis C virus (HCV) genotype, and histologic diagnosis. 106 international centers. 950 nonresponders to 12 or more weeks of therapy with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.